Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. · 2020

Read Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. by Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7231123.txt.

Introduction

Grant and co-authors review evidence that vitamin D supplements could cut the risk of influenza and COVID-19. Their article appeared in Nutrients. The pandemic created urgent demand for added protection beyond quarantine. Vitamin D is known to support immune defense in several ways. It prompts the body to make antimicrobial peptides that slow viruses.

It also lowers levels of inflammatory cytokines that damage lung lining. That injury is what turns infection into pneumonia. The authors connect these mechanisms to patterns in flu and COVID-19 data. Winter outbreaks and latitude gradients enter their argument. They propose supplementation as a low-cost extra measure. The review is careful to rest on prior respiratory infection trials. It frames vitamin D as support, not a substitute for other measures.

Catalog record

CREATORGrant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7231123

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths By William B Grant, Henry Lahore, Sharon L McDonnell, Carole A Baggerly, Christine B French, Jennifer L Aliano, Harjit P Bhattoa Published in: Nutrients DOI: 10.3390/nu12040988 ABSTRACT Abstract The world is in the grip of the COVID-19 pandemic. Public health measures that can reduce the risk of infection and death in addition to quarantines are desperately needed. This article reviews the roles of vitamin D in reducing the risk of respiratory tract infections, knowledge about the epidemiology of influenza and COVID-19, and how vitamin D supplementation might be a useful measure to reduce risk. Through several mechanisms, vitamin D can reduce risk of infections. Those mechanisms include inducing cathelicidins and defensins that can lower viral replication rates and reducing concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia, as well as increasing concentrations of anti-inflammatory cytokines. Several observational studies and clinical trials reported that vitamin D supplementation reduced the risk of influenza, whereas others did not. Evidence supporting the role of vitamin D in reducing risk of COVID-19 includes that the outbreak occurred in winter, a time when 25-hydroxyvitamin D (25(OH)D) concentrations are lowest; that the number of cases in the Southern Hemisphere near the end of summer are low; that vitamin D deficiency has been found to contribute to acute respiratory distress syndrome; and that case-fatality rates increase with age and with chronic disease comorbidity, both of which are associated with lower 25(OH)D concentration. To reduce the risk of infection, it is recommended that people at risk of influenza and/or COVID-19 consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly raise 25(OH)D concentrations, followed by 5000 IU/d. The goal should be to raise 25(OH)D concentrations above 40–60 ng/mL (100–150 nmol/L). For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations. Keywords: acute respiratory distress syndrome (ARDS), ascorbic acid, cathelicidin, coronavirus, COVID-19, cytokine storm, influenza, observational, pneumonia, prevention, respiratory tract infection, solar radiation, treatment, UVB, vitamin C, vitamin D 1. INTRODUCTION The world is now experiencing its third major epidemic of coronavirus (CoV) infections. A new CoV infection epidemic began in Wuhan, Hubei, China, in late 2019, originally called 2019-nCoV [1] and renamed COVID-19 by the World Health Organization on February 11, 2020. Previous CoV epidemics include severe acute respiratory syndrome (SARS)-CoV, which started in China in 2002 [2], and the ongoing Middle East respiratory syndrome (MERS)-CoV in the Middle East, first reported in 2012 [3]. Those epidemics all began with animal-to-human infection. The direct cause of death is generally due to ensuing severe atypical pneumonia [4,5]. Seasonal influenza has a high health burden. According to one recent estimate, 389,000 (uncertainty range 294,000–518,000) respiratory deaths were associated with influenza during the period 2002–2011 [6]. According to the U.S. Center for Disease Control and Prevention, during the period 2010–2019, annual symptomatic illness affected between 9 and 45 million people, resulting in between 4 and 21 million medical visits, 140,000–810,000 hospitalizations, and 23,000–61,000 deaths (https://www.cdc.gov/flu/about/burden/). This review is a narrative one. Searches were made in PubMed.gov and scholar.google.com for publications regarding influenza, CoVs, COVID-19, and pneumonia with respect to epidemiology, innate and adaptive immune response, vitamin D, 25-hydroxyvitamin D (25(OH)D), and parathyroid hormone. 2. VITAMIN D AND MECHANISMS TO REDUCE MICROBIAL INFECTIONS The general metabolism and actions of vitamin D are well known [7]. Vitamin D3 is produced in the skin through the action of UVB radiation reaching 7-dehydrocholesterol in the skin, followed by a thermal reaction. That vitamin D3 or oral vitamin D is converted to 25(OH)D in the liver and then to the hormonal metabolite, 1,25(OH)2D (calcitriol), in the kidneys or other organs as needed. Most of vitamin D’s effect arises from calcitriol entering the nuclear vitamin D receptor, a DNA binding protein that interacts directly with regulatory sequences near target genes and that recruits chromatin active complexes that participate genetically and epigenetically in modifying transcriptional output [8]. A well-known function of calcitriol is to help regulate serum calcium concentrations, which it does in a feedback loop with parathyroid hormone (PTH), which itself has many important functions in the body [7]. Several reviews consider the ways in which vitamin D reduces the risk of viral infections [9,10,11,12,13,14,15,16,17]. Vitamin D has many mechanisms by which it reduces the risk of microbial infection and death. A recent review regarding the role of vitamin D in reducing the risk of the common cold grouped those mechanisms into three categories: physical barrier, cellular natural immunity, and adaptive immunity [16]. Vitamin D helps maintain tight junctions, gap junctions, and adherens junctions (e.g., by E-cadherin) [18]. Several articles discussed how viruses disturb junction integrity, increasing infection by the virus and other microorganisms [19,20,21]. Vitamin D enhances cellular innate immunity partly through the induction of antimicrobial peptides, including human cathelicidin, LL-37, by 1,25-dihdroxyvitamin D [22,23], and defensins [24]. Cathelicidins exhibit direct antimicrobial activities against a spectrum of microbes, including Gram-positive and Gram-negative bacteria, enveloped and nonenveloped viruses, and fungi [25]. Those host-derived peptides kill the invading pathogens by perturbing their cell membranes and can neutralize the biological activities of endotoxins [26]. They have many more important functions, as described therein. In a mouse model, LL-37 reduced influenza A virus replication [27]. In another laboratory study, 1,25(OH)2D reduced the replication of rotavirus both in vitro and in vivo by another process [28]. A clinical trial reported that supplementation with 4000 IU/d of vitamin D decreased dengue virus infection [29]. Vitamin D also enhances cellular immunity, in part by reducing the cytokine storm induced by the innate immune system. The innate immune system generates both pro-inflammatory and anti-inflammatory cytokines in response to viral and bacterial infections, as observed in COVID-19 patients [30]. Vitamin D can reduce the production of pro-inflammatory Th1 cytokines, such as tumor necrosis factor α and interferon γ [31]. Administering vitamin D reduces the expression of pro-inflammatory cytokines and increases the expression of anti-inflammatory cytokines by macrophages ([17] and references therein). Vitamin D is a modulator of adaptive immunity [16,32]; 1,25(OH)2D3 suppresses responses mediated by the T helper cell type 1 (Th1), by primarily repressing production of inflammatory cytokines IL-2 and interferon gamma (INFγ) [33]. Additionally, 1,25(OH)2D3 promotes cytokine production by the T helper type 2 (Th2) cells, which helps enhance the indirect suppression of Th1 cells by complementing this with actions mediated by a multitude of cell types [34]. Furthermore, 1,25(OH)2D3 promotes induction of the T regulatory cells, thereby inhibiting inflammatory processes [35]. Serum 25(OH)D concentrations tend to decrease with age [36], which may be important for COVID-19 because case-fatality rates (CFRs) increase with age [37]. Reasons include less time spent in the sun and reduced production of vitamin D as a result of lower levels of 7-dehydrocholesterol in the skin [38]. In addition, some pharmaceutical drugs reduce serum 25(OH)D concentrations by activating the pregnane-X receptor [39]. Such drugs include antiepileptics, antineoplastics, antibiotics, anti-inflammatory agents, antihypertensives, antiretrovirals, endocrine drugs, and some herbal medicines. Pharmaceutical drug use typically increases with age. Vitamin D supplementation also enhances the expression

Read the complete text